Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
40.42
-0.33 (-0.81%)
At close: Sep 4, 2026, 4:00 PM EDT
39.31
-1.11 (-2.75%)
After-hours: Sep 4, 2026, 7:45 PM EDT
Parabilis Medicines Market Cap
Parabilis Medicines has a market cap or net worth of $4.99 billion as of September 4, 2026.
Market Cap
4.99B
Enterprise Value
3.92B
1-Year Change
n/a
Ranking
Category
Stock Price
$40.42
ChartMarket Cap Chart
Since the IPO on June 10, 2026, Parabilis Medicines's market cap has increased from $2.38B to $4.99B, an increase of 110.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.99B | -0.81% |
| Sep 3, 2026 | 5.03B | 1.60% |
| Sep 2, 2026 | 4.95B | 1.62% |
| Sep 1, 2026 | 4.88B | 1.18% |
| Aug 31, 2026 | 4.82B | -0.26% |
| Aug 28, 2026 | 4.83B | -0.46% |
| Aug 27, 2026 | 4.85B | 0.08% |
| Aug 26, 2026 | 4.85B | 0.08% |
| Aug 25, 2026 | 4.85B | 2.08% |
| Aug 24, 2026 | 4.75B | -2.36% |
| Aug 21, 2026 | 4.86B | -0.56% |
| Aug 20, 2026 | 4.89B | -4.21% |
| Aug 19, 2026 | 5.10B | 5.01% |
| Aug 18, 2026 | 4.86B | 5.72% |
| Aug 17, 2026 | 4.60B | 0.40% |
| Aug 14, 2026 | 4.58B | 3.92% |
| Aug 13, 2026 | 4.41B | -7.50% |
| Aug 12, 2026 | 4.76B | 2.58% |
| Aug 11, 2026 | 4.64B | 2.07% |
| Aug 10, 2026 | 4.55B | 2.14% |
| Aug 7, 2026 | 4.45B | -1.69% |
| Aug 6, 2026 | 4.53B | 1.95% |
| Aug 5, 2026 | 4.44B | -2.79% |
| Aug 4, 2026 | 4.57B | 5.71% |
| Aug 3, 2026 | 4.32B | -0.06% |
| Jul 31, 2026 | 4.33B | 5.27% |
| Jul 30, 2026 | 4.11B | 1.57% |
| Jul 29, 2026 | 4.05B | -0.56% |
| Jul 28, 2026 | 4.07B | 0.44% |
| Jul 27, 2026 | 4.05B | 1.73% |
| Jul 24, 2026 | 3.98B | -4.66% |
| Jul 23, 2026 | 4.18B | 6.49% |
| Jul 22, 2026 | 3.92B | 2.56% |
| Jul 21, 2026 | 3.83B | 10.00% |
| Jul 20, 2026 | 3.48B | -7.58% |
| Jul 17, 2026 | 3.76B | 1.69% |
| Jul 16, 2026 | 3.70B | -2.84% |
| Jul 15, 2026 | 3.81B | -3.98% |
| Jul 14, 2026 | 3.97B | 5.13% |
| Jul 13, 2026 | 3.77B | -3.07% |
| Jul 10, 2026 | 3.89B | 0.69% |
| Jul 9, 2026 | 3.87B | -1.52% |
| Jul 8, 2026 | 3.93B | 1.58% |
| Jul 7, 2026 | 3.86B | 3.94% |
| Jul 6, 2026 | 3.72B | -1.28% |
| Jul 2, 2026 | 3.77B | 6.56% |
| Jul 1, 2026 | 3.53B | 1.42% |
| Jun 30, 2026 | 3.49B | -6.24% |
| Jun 29, 2026 | 3.72B | 1.35% |
| Jun 26, 2026 | 3.67B | 9.26% |
| Jun 25, 2026 | 3.36B | -3.51% |
| Jun 24, 2026 | 3.48B | -0.69% |
| Jun 23, 2026 | 3.50B | -0.11% |
| Jun 22, 2026 | 3.51B | 6.54% |
| Jun 18, 2026 | 3.29B | -0.69% |
| Jun 17, 2026 | 3.31B | -2.11% |
| Jun 16, 2026 | 3.39B | 6.32% |
| Jun 15, 2026 | 3.18B | -8.25% |
| Jun 12, 2026 | 3.47B | -3.07% |
| Jun 11, 2026 | 3.58B | 50.78% |
| Jun 10, 2026 | 2.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 5.79B |
| PTC Therapeutics | 5.78B |
| Ligand Pharmaceuticals | 5.69B |
| Erasca | 5.66B |
| CRISPR Therapeutics AG | 5.39B |
| Definium Therapeutics | 5.12B |
| ACADIA Pharmaceuticals | 4.83B |
| Celcuity | 4.68B |